A Study to Evaluate the Safety and Tolerability of RO7296682 in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study of Olaparib (MK-7339) in Combination With Pembrolizumab (MK-3475) in the Treatment of Homologous Recombination Repair Mutation (HRRm) and/or Homologous Recombination Deficiency (HRD)-Positive Advanced Cancer (MK-7339-007/KEYLYNK-007)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin
- Status
- COMPLETED
- Phase
- PHASE1
A Study Evaluating the Safety, Tolerability, Pharmacokinetics and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
- Status
- UNKNOWN
- Phase
- NA
A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of MEDI1191 in Sequential and Concurrent Combination With Durvalumab in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of Anetumab Ravtansine in Adults With Solid Tumors Who Have Been Treated in Previous Bayer-sponsored Anetumab Ravtansine Studies
- Status
- TERMINATED
- Phase
- PHASE2
GEN1046 Safety Trial in Patients With Malignant Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Pembrolizumab Following Surgery in Patients With Microsatellite Instability High (MSI-H) Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Avelumab Program Rollover Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of the Effects of Pre-surgical Aerobic Exercise on Patients With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of MK-8353 + Selumetinib in Advanced/Metastatic Solid Tumors (MK-8353-014)
- Status
- COMPLETED
- Phase
- PHASE1